Coronary/Structural Heart

Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies Press Release by Victoria John Creavo Medical Technologies, the UK-based med-tech company, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP […]

LifeTech announced the launch of its global post-market surveillance study for LAmbre (TM) LAA Closure System

NEWS PROVIDED BY LifeTech Scientific Corporation 03 Jul, 2017, 11:56 BST FRANKFURT, Germany, July 3, 2017 /PRNewswire/ — On June 30, at the Congenital and Structural Intervention Congress (CSI) 2017 in Frankfurt, LifeTech Scientific Corporation (Stock Code: 1302.HK) announced the launch of a 3-year global post-market surveillance (PMS) study for the LAmbreTM Left Atrial Appendage (LAA) Closure […]

GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration

WASHINGTON–(BUSINESS WIRE)–GE Healthcare and HeartFlow, Inc. announced today at SCCT2017, the annual scientific meeting of the Society of Cardiovascular Computed Tomography, that they have entered into a global collaboration agreement with the goal of increasing the clinical availability and adoption of HeartFlow FFRct, a proprietary technology that helps clinicians diagnose and treat […]

HeartFlow Announces American Medical Association Issues Unique Category III CPT Codes For HeartFlow FFRct

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that the American Medical Association (AMA) has issued a set of new Category III Current Procedural Terminology (CPT®) codes for HeartFlow® FFRct, a first-of-its-kind noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). The CPT code application was submitted […]

Edwards Lifesciences (EW)’ INSPIRIS RESILIA Valve Wins FDA Approval

IRVINE, Calif., July 5, 2017/PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received U.S. Food and Drug Administration (FDA) approval for its INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves. […]

3-D Printed Models Could Improve Patient Outcomes in Heart Valve Replacements

Article ID: 677120 Released: 27-Jun-2017 11:45 AM EDT Source Newsroom: Georgia Institute of Technology Newswise — Heart valve models created with advanced 3-D printers could soon assist cardiologists in preparing to perform life-saving heart valve replacements. Researchers at Georgia Institute of Technology and the Piedmont Heart Institute are using standard medical imaging and […]

New Study With Abiomed (ABMD)’s Impella 2.5 Heart Pump Demonstrates Potential Survival With Pre-PCI Insertion In Heart Attacks With The Left Main Coronary Artery

DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a peer-reviewed retrospective study on hemodynamic support with the Impella 2.5® heart pump. The study analyzed patients with acute myocardial infarction complicated by cardiogenic shock […]

Treating Lymphatic Fluid Leaks Improves Severe Protein Loss in Patients with Single-ventricle Heart Disease

NEWS PROVIDED BY Children’s Hospital of Philadelphia 10:00 ET PHILADELPHIA, June 29, 2017 /PRNewswire-USNewswire/ — Focusing on a rare but devastating complication in patients with single-ventricle heart disease, a research team has revealed the role of leakage from the liver’s lymphatic system, and used a novel procedure to seal off those leaks and improve […]